Rice Hall James & Associates, LLC 13F Holdings · Q2 2026
Rice Hall James & Associates, LLC reported 240 securities worth $2.05B in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: LGND (4.15%), ACIW (2.46%), ARLO (2.45%). Among its top 25 positions this quarter: 1 new, 18 added, 6 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | LGND | LIGAND PHARMACEUTICALS INC | $85.4M | 4.15% | 270,052 | Trimmed |
| 2 | ACIW | ACI WORLDWIDE INC | $50.6M | 2.46% | 1.0M | Added |
| 3 | ARLO | ARLO TECHNOLOGIES INC | $50.3M | 2.45% | 3.7M | Added |
| 4 | FN | FABRINET | $49.2M | 2.40% | 87,577 | Trimmed |
| 5 | ESTA | ESTABLISHMENT LABS HLDGS INC | $48.1M | 2.34% | 560,935 | Added |
| 6 | XPO | XPO INC | $46.2M | 2.25% | 224,878 | Added |
| 7 | ZD | ZIFF DAVIS INC | $43.0M | 2.09% | 821,496 | Added |
| 8 | FOUR | SHIFT4 PMTS INC | $42.5M | 2.07% | 874,492 | Added |
| 9 | KNSA | KINIKSA PHARMACEUTICALS INTL | $40.0M | 1.95% | 624,928 | Added |
| 10 | ASND | ASCENDIS PHARMA A/S | $39.6M | 1.93% | 148,644 | New |
| 11 | LRN | STRIDE INC | $37.9M | 1.84% | 438,981 | Added |
| 12 | PBH | PRESTIGE CONSMR HEALTHCARE I | $32.6M | 1.59% | 689,692 | Added |
| 13 | DFIN | DONNELLEY FINL SOLUTIONS INC | $32.5M | 1.58% | 775,119 | Trimmed |
| 14 | ITRN | ITURAN LOCATION AND CONTROL | $29.0M | 1.41% | 475,496 | Trimmed |
| 15 | MEDP | MEDPACE HLDGS INC | $28.7M | 1.39% | 54,116 | Added |
| 16 | AWI | ARMSTRONG WORLD INDS INC NEW | $28.4M | 1.38% | 177,147 | Added |
| 17 | GDDY | GODADDY INC | $28.1M | 1.37% | 330,474 | Added |
| 18 | BIRK | BIRKENSTOCK HOLDING PLC | $27.1M | 1.32% | 629,868 | Added |
| 19 | YOU | CLEAR SECURE INC | $27.0M | 1.32% | 485,011 | Trimmed |
| 20 | NGVT | INGEVITY CORP | $26.2M | 1.28% | 351,203 | Added |
| 21 | WEX | WEX INC | $25.2M | 1.23% | 178,606 | Trimmed |
| 22 | LQDT | LIQUIDITY SVCS INC | $23.8M | 1.16% | 608,476 | Added |
| 23 | SRAD | SPORTRADAR GROUP AG | $23.9M | 1.16% | 1.6M | Added |
| 24 | AGM | FEDERAL AGRIC MTG CORP | $23.5M | 1.15% | 118,094 | Added |
| 25 | BCRX | BIOCRYST PHARMACEUTICALS INC | $23.3M | 1.13% | 2.3M | Added |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR